##### Table of Contents



SECURITIES AND EXCHANGE COMMISSION
 Washington, D.C. 20549
 FORM 10-QSB
 þ
    
    QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (D)
OF THE SECURITIES EXCHANGE ACT OF 1934
 For the Quarterly Period Ended: March 31, 2008
 o
    
    TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (D)
OF THE SECURITIES EXCHANGE ACT OF 1934
 For transition period from  to
 Commission File Number: 000-25548
 SUTURA, INC.
 (Name of small business issuer in its charter)
 Delaware
    
    84-1010269(State or other jurisdiction of
    
    (I.R.S. Employer Identification No.)incorporation or organization)
 
   
  þ o
  o þ
  o þ




---



##### 



PART I

3Item 1. Financial Statements

3Consolidated Balance Sheet on March 31, 2008 (Unaudited)

3Consolidated Statement of Operations for the three month
periods ended March 31, 2008 and 2007 (Unaudited)

4Consolidated Statement of Cash Flows for the three
month periods ended March 31, 2008 and 2007 (Unaudited)

5Notes to Consolidated Financial Statements (Unaudited)Item 2. Managements Discussion and Analysis of Financial Condition
and Results of Operations

24Item 3. Controls and Procedures

30PART II

30Item 1. Legal Proceedings

30Item 2. Changes In Securities

31Item 3. Defaults Upon Senior Securities

31Item 4. Submission of Matters to a Vote of Security Holders

31Item 5. Other Information

31Item 6. Exhibits and Reports on Form 8-K

32Signatures

35EXHIBIT 31.1EXHIBIT 31.2EXHIBIT 32.1
  2




---



##### Table of Contents



ASSETSCURRENT ASSETS:Cash & cash equivalents
    
    $
    2,642,263Marketable securities
    
    
    10,898,414Certificates of deposit  Short term
    
    
    1,421,606Accounts receivable, net
    
    
    37,203Inventory, net
    
    
    331,722Prepaid expenses
    
    
    56,991Total current assets
    
    
    15,388,199LONG TERM ASSETSProperty & equipment, net
    
    
    505,882Certificates of deposit  Long term
    
    
    668,180Deposits
    
    
    283,077Total long term assets
    
    
    1,457,139$
    16,845,338LIABILITIES AND STOCKHOLDERS DEFICITCURRENT LIABILITIES:Accounts payable and accrued expenses
    
    $
    1,910,913Loan payable  officers
    
    
    124,906Customer deposits
    
    
    976,643Notes payable  related party
    
    
    189,115Convertible notes payable- officers
    
    
    1,000,519Convertible notes payable- net of beneficial conversion
    
    
    3,907,208Total current liabilities
    
    
    8,109,304LONG TERM LIABILITIES:Convertible notes payable- net of beneficial conversion
    
    
    16,956,770Notes payables
    
    
    1,700,000Notes payables officers
    
    
    400,000Total long term liabilities
    
    
    19,056,770COMMITMENTS AND CONTINGENCIES
    
    
    STOCKHOLDERS DEFICITSeries A convertible preferred stock,
$0.001 par value;
2,000,000 shares authorized, none issued and outstanding
    
    
    Common stock, $0.001 par value; 500,000,000
shares authorized;
272,650,262 shares issued and outstanding
    
    
    272,650Additional paid in capital
    
    
    51,066,971Accumulated deficit
    
    
    (60,681,937
    )Other comprehensive loss
    
    
    (978,420
    )Total stockholders deficit
    
    
    (10,320,736
    )$
    16,845,338
  3




---



##### Table of Contents



2008
    
    
    2007NET SALES
    
    $
    52,380
    
    
    $
    81,616COST OF
GOODS SOLD (1)
    
    
    563,735
    
    
    
    482,317GROSS LOSS
    
    
    (511,355
    )
    
    
    (400,701
    )OPERATING EXPENSES:Research and
development (1)
    
    
    223,422
    
    
    
    162,591General and
administrative (1)
    
    
    1,191,416
    
    
    
    1,191,384Sales and
marketing (1)
    
    
    151,146
    
    
    
    153,259Total operating expenses
    
    
    1,565,984
    
    
    
    1,507,234OPERATING LOSS
    
    
    (2,077,340
    )
    
    
    (1,907,935
    )OTHER INCOME (EXPENSE)Interest Income
    
    
    168,167
    
    
    
    6,935Interest
Expense (2)
    
    
    (1,126,026
    )
    
    
    (1,071,225
    )Other Income
    
    
    15,000
    
    
    
    Total other expense, net
    
    
    (942,858
    )
    
    
    (1,064,290
    )NET LOSS
    
    
    (3,020,198
    )
    
    
    (2,972,224
    )OTHER
COMPREHENSIVE GAIN (LOSS)Unrealized
gain (loss) on marketable securities
    
    
    130,287
    
    
    
    Foreign translation adjustment
    
    
    (50,471
    )
    
    
    (8,249
    )COMPREHENSIVE LOSS
    
    $
    (2,940,382
    )
    
    $
    (2,980,474
    )BASIC AND DILUTED NET LOSS PER SHARE
    
    $
    (0.01
    )
    
    $
    (0.01
    )BASIC AND DILUTED WEIGHTED AVERAGE
SHARES OUTSTANDING*
    
    
    272,650,262
    
    
    
    259,168,108*  Weighted average number of shares used to
compute basic and diluted income(loss)
per share is the same since the effect
of dilutive securities is anti-dilutive.(1)  Includes
stock-based compensation charges (credits) of:Cost of good sold
    
    $
    15,128
    
    
    $
    15,128Research and development
    
    
    14,208
    
    
    
    14,208General and administrative
    
    
    47,556
    
    
    
    49,115Sales and Marketing
    
    
    4,181
    
    
    
    4,181(2)  Includes amortization of beneficial conversion
feature and fair value of warrants of:
    
    $
    357,415
    
    
    $
    569,949
  4




---



##### Table of Contents



2008
    
    
    '2007CASH FLOWS FROM OPERATING ACTIVITIES:Net loss
    
    $
    (3,020,198
    )
    
    $
    (2,972,224
    )Adjustments to reconcile net loss to net cash
used in operating activitiesDepreciation and amortization
    
    
    36,174
    
    
    
    57,372Provision for doubtful debts
    
    
    
    
    
    
    Beneficial conversion feature
    
    
    357,415
    
    
    
    569,949Stock based compensation expenses- employees
    
    
    81,073
    
    
    
    82,632Stock based compensation expenses- non employees
    
    
    44,569
    
    
    
    34,838Interest expenses converted into shares
    
    
    
    
    
    
    470,500(Increase) decrease in current assets:Accounts receivables
    
    
    (2,862
    )
    
    
    (15,167
    )Inventory
    
    
    82,102
    
    
    
    58,117Prepaid expenses
    
    
    (7,250
    )
    
    
    (94,914
    )Increase (decrease) in current liabilities:Accounts payable and accrued liabilities
    
    
    158,452
    
    
    
    20,965Accrued payroll
    
    
    (1,490,428
    )
    
    
    (6,552
    )Customer deposits
    
    
    (29,668
    )
    
    
    (17,375
    )Total adjustments
    
    
    (770,422
    )
    
    
    1,160,364Net cash used in operating activities
    
    
    (3,790,620
    )
    
    
    (1,811,860
    )CASH FLOWS INVESTING ACTIVITIES:Acquisition of property and equipment, net
    
    
    (290,121
    )
    
    
    (35,439
    )CASH FLOWS FROM FINANCING ACTIVITIES:Proceeds from (payments to) notes payable
    
    
    (100,000
    )
    
    
    1,500,000Purchases of marketable securities
    
    
    (953,687
    )
    
    
    Net cash provided by (used in) financing activities
    
    
    (1,053,687
    )
    
    
    1,500,000Effect of rate changes on cash and cash equivalents
    
    
    9,494
    
    
    
    1,561NET DECREASE IN CASH & CASH EQUIVALENTS
    
    
    (5,124,933
    )
    
    
    (345,738
    )CASH & CASH EQUIVALENTS, BEGINNING BALANCE
    
    
    7,767,196
    
    
    
    1,238,154CASH & CASH EQUIVALENTS, ENDING BALANCE
    
    $
    2,642,263
    
    
    $
    892,417SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:Interest paid
    
    $
    627,937
    
    
    $
    Income taxes
    
    $
    
    
    
    $
    
  5




---



##### Table of Contents



6




---



##### Table of Contents



7




---



##### Table of Contents



8




---



##### Table of Contents



9




---



##### Table of Contents



,
   10




---



##### Table of Contents



AggegrateWeighted
    
    
    IntrinsicTotal
    
    
    price
    
    
    ValueOUTSTANDING, DECEMBER 31, 2007
    
    
    45,017,899
    
    
    $
    0.101
    
    
    $
    691,890Granted in 2008
    
    
    Cancelled in 2008
    
    
    Exercised in 2008
    
    
    OUTSTANDING, MARCH 31, 2008
    
    
    45,017,899
    
    
    $
    0.101
    
    
    $
    691,890
     Acquisition
    
    
    Market
    
    
    Accumulatedcost at
    
    
    value at
    
    
    unrealizedMarch 31 2008
    
    
    March 31 2008
    
    
    Gain (Loss)Taxable auction rate securities
    
    $
    4,000,232
    
    
    $
    4,000,000
    
    
    $
    (232
    )Government bonds
    
    
    6,323,402
    
    
    
    6,408,709
    
    
    
    85,307Corporate bonds
    
    
    481,436
    
    
    
    489,705
    
    
    
    8,269Totals
    
    $
    10,805,070
    
    
    $
    10,898,414
    
    
    $
    93,344
  Acquisition
    
    
    Market
    
    
    Accumulatedcost at
    
    
    value at
    
    
    unrealizedMarch 31 2008
    
    
    March 31 2008
    
    
    LossCertificates of deposit  Short Term
    
    $
    1,426,029
    
    
    $
    1,421,606
    
    
    $
    (4,423
    )Certificates of deposit  Long Term
    
    
    671,085
    
    
    
    668,180
    
    
    $
    (2,905
    )$
    2,097,114
    
    
    $
    2,089,786
    
    
    $
    (7,328
    )
   11




---



##### Table of Contents



Inventory
 March 312008Raw material/WIP
    
    $
    514,491Work in process
    
    
    72,863Finished goods
    
    
    94,368681,722Less: Reserve for obsolescence
    
    
    (350,000
    )$
    331,722
   Property Plant & equipment
 March 312008Computers
    
    $
    393,475Office furniture and fixtures
    
    
    587,997Machinery and equipment
    
    
    2,777,9883,759,462Less: Accumulated depreciation
    
    
    (3,253,580
    )$
    505,882Depreciation expense recorded for the three month periods
ended March 31, 2008 and 2007 was $36,172 and $57,372, respectively.
   Accounts payables
 March 312008Accounts payable   trade creditors
    
    $
    241,716Accounts payable   legal and professional
    
    
    53,646Accrued expenses
    
    
    166,748Accrued compensation
    
    
    615,825Accrued interest payable
    
    
    832,979$
    1,910,913
     12




---



##### Table of Contents



Deposits
 March 312008Ending balance per December 31st, 2007
    
    $
    1,006,311Applied against shipments
    
    
    29,668Ending balance per March 31, 2008
    
    $
    976,643
  st
  Notes payables related party
 March 312008Notes payable with interest at 8%
due and demandable on December 31, 2007
    
    $
    189,115
     Notes payables-officers
 March 312008Convertible notes payable to officer
bearing interest rate of 10%, unsecured
    
    $
    1,000,519
  Intrinsic
    
    
    Intrinsic
    
    
    Intrinsic
    
    
    Intrinsic
    
    
    IntrinsicConversion
    
    
    Conversion
    
    
    value per
    
    
    value per end
    
    
    value per end
    
    
    value per end
    
    
    value per endshares
    
    
    price
    
    
    December
    
    
    March
    
    
    June
    
    
    Sept
    
    
    DecRatering
    
    
    12,506,488
    
    
    $
    0.0800
    
    
    $
    
    
    
    $
    
    
    
    $
    
    
    
    $
    
    
    
    $
 13




---



##### Table of Contents



14




---



##### Table of Contents



15




---



##### Table of Contents



16




---



##### Table of Contents



17




---



##### Table of Contents



18




---



##### Table of Contents



1.
    
    the shares of Common Stock issuable upon conversion of any principal or interest due
under any notes issued in connection with any of the Whitebox financings;2.
    
    the shares of Common Stock issued in connection with any Whitebox financings;3.
    
    the shares of Common Stock issuable upon exercise of any warrants issued in connection
with any Whitebox financings; and4.
    
    the shares of Common Stock issuable upon conversion of principal or interest due under
the note issued to Synapse Capital, LLC in connection with the settlement of the
shareholder litigation.
    19




---



##### Table of Contents



Convertible notes payables
 March 312008Whitebox I
    
    $
    6,746,500Whitebox Ia
    
    
    202,395Whitebox II
    
    
    3,090,000Whitebox IIa
    
    
    92,700Whitebox III
    
    
    7,210,000Whitebox IIIa
    
    
    162,625Whitebox V
    
    
    1,500,000Whitebox Va
    
    
    30,000Whitebox VI
    
    
    1,500,000Whitebox VIa
    
    
    30,000Synapse settlement note
    
    
    400,000Whitebox VIII
    
    
    1,000,000$
    21,964,220Debt issue costs
    
    
    (116,997
    )Loan consent fees
    
    
    (310,311
    )Beneficial conversion feature
    
    
    (672,934
    )$
    20,863,978Classified as current liability
    
    $
    3,907,208Classified as long term liability
    
    $
    16,956,770
   Convers
    
    
    Intrinsic
    
    
    Intrinsic
    
    
    Intrinsic
    
    
    Intrinsic
    
    
    IntrinsicConversion
    
    
    ion
    
    
    value per
    
    
    value per end
    
    
    value per
    
    
    value per
    
    
    value pershares
    
    
    price
    
    
    December
    
    
    March
    
    
    end June
    
    
    end Sept
    
    
    end DecWhitebox I
    
    
    84,331,250
    
    
    
    0.0800
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    Whitebox Ia
    
    
    2,529,938
    
    
    
    0.0800
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    Whitebox II
    
    
    38,625,000
    
    
    
    0.0800
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    Whitebox IIa
    
    
    1,158,750
    
    
    
    0.0800
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    Whitebox III
    
    
    90,125,000
    
    
    
    0.0800
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    Whitebox IIIa
    
    
    2,032,813
    
    
    
    0.0800
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    Whitebox V
    
    
    33,333,333
    
    
    
    0.0450
    
    
    
    500,000
    
    
    
    500,000Whitebox Va
    
    
    666,667
    
    
    
    0.0450
    
    
    
    10,000
    
    
    
    10,000Whitebox VI
    
    
    33,333,333
    
    
    
    0.0450
    
    
    
    500,000
    
    
    
    500,000Whitebox VIa
    
    
    666,667
    
    
    
    0.0450
    
    
    
    10,000
    
    
    
    10,000Synapse
    
    
    2,666,667
    
    
    
    0.1500
    
    
    
    
    
    
    
    Whitebox VIII
    
    
    14,285,714
    
    
    
    0.0700
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    303,755,131
    
    
    
    
    
    
    $
    1,020,000
    
    
    $
    1,020,000
    
    
    $
    0
    
    
    $
    0
    
    
    $
    0
    20




---



##### Table of Contents



plus
 plus
  Notes
payables
 March 312008Whitebox VII
    
    $
    1,700,000
  plus
 Notes
payables officers
 March 312008GrootKasteel
    
    $
    200,000Teckman
    
    
    100,000Bjorkman
    
    
    100,000$
    400,000
   21




---



##### Table of Contents



Remaining
    
    
    AggregateLife in
    
    
    IntrinsicTotal
    
    
    Price
    
    
    years
    
    
    ValueWarrants issued in 2004
    
    
    6,311,951
    
    
    $
    0.6259
    
    
    
    1.0
    
    
    $Warrants Fusion
    
    
    1,220,565
    
    
    
    0.4464
    
    
    
    2.0Warrants Whitebox I
    
    
    14,423,512
    
    
    
    0.4541
    
    
    
    1.5Warrants Whitebox II
    
    
    1,666,667
    
    
    
    0.4500
    
    
    
    2.0Warrants Whitebox III
    
    
    1,609,197
    
    
    
    0.4500
    
    
    
    2.4Warrants Whitebox IV
    
    
    10,400,000
    
    
    
    0.0913
    
    
    
    3.7Cancelled in 2007
    
    
    
    
    
    
    
    
    
    
    Exercised in 2007
    
    
    
    
    
    
    
    
    
    
    Outstanding December 2007
    
    
    35,631,891
    
    
    $
    0.3780
    
    
    
    2.1
    
    
    $
    
     22




---



##### Table of Contents



Millenium Litigation
  Pham v. Nobles, et al.
     Recent Conversions of Debt-to-Equity by Whitebox Affiliates
  Whitebox Convertible Arbitrage Partners, L.P. 
    
    
    25,859,437Whitebox Hedged High yield Partners, L.P. 
    
    
    20,687,550Whitebox Intermarket Partners, L.P. 
    
    
    8,275,012Pandora Select Partners, L.P. 
    
    
    10,343,775
 23




---



##### Table of Contents



Officer and Director Appointments
  Past Officer Litigation
  
 Item 2.
     24




---



##### Table of Contents



25




---



##### Table of Contents



26




---



##### Table of Contents



Financial Condition and Results of Operations for the three month periods ended March 31, 2008
compared to three month period ended March 31, 2007
  27




---



##### Table of Contents



28




---



##### Table of Contents



Three months
    
    
    Three months2008
    
    
    2007Interest expenses.Note payable related party in Euros
    
    $
    3,608
    
    
    $
    2,915Note payable officer
    
    
    25,013
    
    
    
    18,528Whitebox I
    
    
    202,395
    
    
    
    196,500Whitebox I Consent fee amortization
    
    
    24,563Whitebox Ia Interest note
    
    
    6,072
    
    
    
    Whitebox II
    
    
    92,700
    
    
    
    90,000Whitebox II Consent fee amortization
    
    
    11,250Whitebox IIa Interest note
    
    
    2,781
    
    
    
    Whitebox III
    
    
    216,300
    
    
    
    140,000Whitebox III Consent fee amortization
    
    
    26,250Whitebox IIIa Interest note
    
    
    4,879
    
    
    
    Idylwood Partners L.P.
    
    
    
    
    
    
    15,000Whitebox V
    
    
    30,000
    
    
    
    30,000Whitebox Va Interest note
    
    
    900
    
    
    
    Whitebox VI
    
    
    30,000
    
    
    
    8,333Whitebox VIa Interest note
    
    
    900
    
    
    
    Synapse
    
    
    8,000
    
    
    
    Whitebox VII
    
    
    51,000
    
    
    
    Notes Officers
    
    
    12,000
    
    
    
    Whitebox VIII
    
    
    20,000
    
    
    
    $
    768,611
    
    
    $
    501,276
 Three months
    
    
    Three months2008
    
    
    2007Beneficial conversion amortizationWhitebox I
    
    $
    
    
    
    $
    291,377Whitebox I BCF consent fee
    
    
    20,420Whitebox II
    
    
    
    
    
    
    33,938Whitebox II BCF consent fee
    
    
    9,353
    
    
    
    Whitebox III
    
    
    170,309
    
    
    
    141,252Whitebox III BCF consent fee
    
    
    21,823
    
    
    
    Idylwood Partners L.P.
    
    
    
    
    
    
    20,833Whitebox V
    
    
    135,510
    
    
    
    82,549Total conversion feature expense
    
    $
    357,415
    
    
    $
    569,949Total interest expenses
    
    $
    1,126,025
    
    
    $
    1,071,225
    29




---



##### Table of Contents



ITEM 3
   
 PART II: OTHER INFORMATION
 
 ITEM 1
   30




---



##### Table of Contents



Pham v. Nobles, et al.
  
 ITEM 2
  
 ITEM 3
  
 ITEM 4
  
 ITEM 5
  31




---



##### Table of Contents



ITEM 6
  3.1
    
    Certificate of Incorporation13.2
    
    Certificate of Amendment to Certificate of Incorporation23.3
    
    Certificate of Amendment to Certificate of Incorporation73.4
    
    Certificate of Merger73.5
    
    Bylaws74.1
    
    Form of Common Stock Certificate110.1
    
    Sutura Inc. 2001 Stock Option Plan710.2
    
    Sutura Inc. 1999 Stock Option Plan710.3
    
    Employment Agreement with Egbert Ratering710.4
    
    Employment Agreement with Anthony Nobles710.5
    
    Sutura Inc. 2006 Stock Option Plan710.6
    
    Lease for Fountain Valley Location710.7
    
    Sucor License Agreement710.8
    
    Sterilis License Agreement710.9
    
    Option and Distribution Agreement with Getz Bros. & Co., Inc., dated September 20, 2002710.10
    
    Convertible Promissory Note in Favor of Getz Bros. & Co., Inc., dated September 20, 2002710.11
    
    Purchase Agreement, dated as of September 17, 2004 by and between Sutura, Inc. and certain
other parties thereto.310.12
    
    Purchase Agreement, dated as of March 24, 2005 by and between Sutura, Inc. and certain other
parties thereto.3
 32




---



##### Table of Contents



10.13
    
    Form of Secured Convertible Promissory Note, dated September 17, 2004.310.14
    
    Form of Secured Convertible Promissory Note dated March 24, 2005.310.15
    
    Form of Warrant, dated September 17, 2004.310.16
    
    Form of Warrant dated, March 24, 2005.310.17
    
    Purchase Agreement, dated September 9, 2005 by and between Sutura, Inc. and certain other
parties thereto.310.18
    
    Second Amended Security Agreement, dated September 9, 2005 by and between Sutura, Inc. and
certain other parties thereto.310.19
    
    Second Amended Patent and Trademark Security Agreement, dated September 7, 2005 by and
between Sutura, Inc. and certain other parties thereto.310.20
    
    Second Amended Registration Rights Agreement, dated September 7, 2005 by and between Sutura,
Inc. and certain other parties thereto.310.21
    
    Form of Secured Convertible Promissory Note, dated September 7, 2005.310.22
    
    Form of Warrant dated September 7, 2004.310.23
    
    Amendment to Secured Convertible Promissory Notes and Warrants, dated September 7, 2005 by
and between Sutura, Inc. and certain other parties thereto.310.24
    
    Amendment to Secured Convertible Promissory Notes and Warrants, dated March 31, 2006 by and
between Sutura, Inc. and certain other parties thereto.410.25
    
    Agreement and Plan of Merger dated November 22, 2004.5
 33




---



##### Table of Contents



10.26
    
    Distributor Agreement with Getz Bros & Co., Inc. dated September 20, 2002.710.27
    
    Distribution Agreement with The Lifemed Group, Inc. dated January 16, 2006.710.28
    
    Form of Secured Convertible Promissory Note,
dated March 5,
2007.810.29
    
    Form of Promissory Note, dated May 18,
2007.910.30
    
    Form of Promissory Note, dated July 2,
2007.1010.31
    
    Form of Promissory Note, dated July 16,
2007.1110.32
    
    Amendment to Secured Promissory Notes, effective
as of July 1,
2007.1210.33
    
    Form of Convertible Promissory Note, dated
September 21,
2007.1310.34
    
    Common Stock Purchase Agreement between Sutura
and Grootkasteel, B.V., dated
November 21,
2007.1410.35
    
    Settlement,
License and Release Agreement between Sutura, Abbott Laboratories and
Abbott Vascular, Inc., effective December 3,
2007.1510.36
    
    Convertible Promissory Note, dated
December 12,
2007.1614.1
    
    Code of ethics for the Board of Directors.614.2
    
    Code of ethics for Executive Officers.631.1
    
    Certification of the Chief Executive Officer of Sutura, Inc. pursuant to Section 302 of the
Sarbanes-Oxley Act of 2002.31.2
    
    Certification of the Chief Financial Officer of Sutura, Inc. pursuant to Section 302 of the
Sarbanes-Oxley Act of 2002.32.1
    
    Certification of the Chief Executive Officer of Sutura, Inc.
pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.32.2
    
    Certification of the Chief Financial Officer of Sutura, Inc.
pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
 
 1
    
    Previously filed as part of the Form 10-KSB filed in
May 1995 and amendments thereto which are hereby incorporated by reference.2
    
    Previously filed as part of the Form 10-KSB for the
period ending December 31, 2001.3
    
    Previously filed as an exhibit to Form 8-K, filed on
September 13, 2005.4
    
    Previously filed as an exhibit to Form 8-K filed on
March 31, 2006.5
    
    Previously filed as an exhibit to Form 8-K filed on
December 1, 2004.6
    
    Previously filed as part of the Form 10-KSB for the
period ending December 31, 2003.7
    
    Previously filed as part of the Form 10-KSB for the period ending December
31, 2005.8
    
    Previously filed as an Exhibit to Form 8-K filed on
March 7, 2007.9
    
    Previously filed as an Exhibit to Form 8-K filed on
May 24, 2007.10
    
    Previously filed as an Exhibit to Form 8-K filed on
July 6, 2007.11
    
    Previously filed as an Exhibit to Form 8-K filed on
July 19, 2007.12
    
    Previously filed as an Exhibit to Form 8-K filed on
September 18, 2007.13
    
    Previously filed as an Exhibit to Form 8-K filed on
September 25, 2007.14
    
    Previously filed as an Exhibit to Form 8-K filed on
November 26, 2007.15
    
    Previously filed as an Exhibit to Form 8-K filed on
December 4, 2007.16
    
    Previously filed as an Exhibit to Form 8-K on
December 17, 2007.   34




---



##### Table of Contents



SUTURA, INC.RegistrantDate: May 20, 2008
    By:
    /s/ Brian AbrahamBrian Abraham, Chief Executive OfficerDate: May 20, 2008
    By:
    /s/ Richard BjorkmanRichard Bjorkman, Chief Financial Officer 35